FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke-Reference-Cited by-同舟云学术

FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke

Published:2013-07-31 Issue:7 Volume:8 Page:e70124
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Brunkhorst Robert,Kanaan Nathalie,Koch Alexander,Ferreirós Nerea,Mirceska Ana,Zeiner Pia,Mittelbronn Michel,Derouiche Amin,Steinmetz Helmuth,Foerch Christian,Pfeilschifter Josef,Pfeilschifter Waltraud

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Heart Disease and Stroke Statistics–2013 Update A Report From the American Heart Association;AS Go;Circulation,2012

2. The influence of gender and age on disability following ischemic stroke: the Framingham study;M Kelly-Hayes;Journal of Stroke and Cerebrovascular Diseases,2003

3. A new penumbra: transitioning from injury into repair after stroke;EH Lo;Nature Medicine,2008

4. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia;B Czech;Biochemical and Biophysical Research Communications,2009

5. Fingolimod provides long-term protection in rodent models of cerebral ischemia;Y Wei;Annals of Neurology,2010

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome Analysis Reveals Dynamic Microglial-Induced A1 Astrocyte Reactivity via C3/C3aR/NF-κB Signaling After Ischemic Stroke;Molecular Neurobiology;2024-05-07

2. Astrocytes in ischemic stroke: Crosstalk in central nervous system and therapeutic potential;Neuropathology;2023-06-21

3. Sphingolipid metabolism and signaling in cardiovascular diseases;Frontiers in Cardiovascular Medicine;2022-08-31

4. Sphingosine‐1‐phosphate receptor modulators in stroke treatment;Journal of Neurochemistry;2022-08-16

5. Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as Comorbidities;Frontiers in Pharmacology;2022-07-13